Showing results (41-50 of 462) with videos related to
Sort By:
Pageof 47
European Journal of Pharmacology|February 18, 1986
Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenicsM Gavish, A Weizman, L Karp, et al.Biological Psychiatry|March 1, 1988
Imipramine binding to platelets of children with attention deficit disorder with hyperactivityA Weizman, E Bernhout, R Weitz, et al.The American Journal of Clinical Nutrition|June 13, 1998
Parents as the exclusive agents of change in the treatment of childhood obesityM Golan, A Weizman, A Apter, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|November 27, 2004
DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescentsG Zalsman, A Frisch, R Lewis, et al.Psychopharmacology|January 1, 1987
Platelet [3H]imipramine binding in autism and schizophreniaA Weizman, N Gonen, S Tyano, et al.Clinical Neuropharmacology|June 1, 1988
Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patientsA Weizman, M Mark, I Gil-Ad, et al.Psychopharmacology|January 1, 1987
The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patientsA Weizman, I Gil-Ad, D Grupper, et al.Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 1, 1992
Cognitive modifiability of adolescents with schizophrenia: a research noteM Skuy, A Apter, Y Dembo, et al.Acta Psychiatrica Scandinavica|February 1, 1990
Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatmentB Spivak, A Weizman, L Wolovick, et al.Neuropsychobiology|January 1, 1989
Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric inpatientsI Modai, A Apter, M Meltzer, et al.Pageof 47